The managed entry of new drugs into a national health service: A case study for Malta, prior to its becoming a Member State of the European Union

 
9783838394268: The managed entry of new drugs into a national health service: A case study for Malta, prior to its becoming a Member State of the European Union
View all copies of this ISBN edition:
 
 

This case study originated from the need and willingness to implement managed change to the policy and practice for the introduction of new drugs into the national health service in Malta. A logic model was used to represent a descriptive evaluation(1999), to prioritise and document changes achieved from planned interventions and to present the final outcome evaluation(2003). This action research presents the subjective opinion of the author at that time. The methodology and findings can be generalised and applied. Hopefully those embarking on a challenge to bring about change in their organisation are encouraged to act. The study was finalised just before Malta's accession to the European Union (EU)(May 2004)and considered the possible impact of accession. With hindsight, the prediction that adoption of EU legislation would introduce a strong pharmaceutical framework which drives required changes and increases transparency in decision making proved to be correct. The issues with availability, affordability and equity of new drugs, which were a problem for Malta in 1999, remain, not only for Malta but also for other countries.

"synopsis" may belong to another edition of this title.

About the Author:

Patricia Vella Bonanno BPharm (Hons), MSc, PhD. Graduated as a pharmacist at the University of Malta in 1991. Did post- graduate studies in medicines management : a Masters with Queen's University of Belfast, Northern Ireland and a Doctorate at The Robert Gordon University, Aberdeen. Currently CEO at the Medicines Authority, Malta.

"About this title" may belong to another edition of this title.

Buy New View Book
List Price: US$ 102.00
US$ 78.93

Convert currency

Shipping: US$ 7.88
From United Kingdom to U.S.A.

Destination, rates & speeds

Add to Basket

Top Search Results from the AbeBooks Marketplace

1.

Patricia Vella Bonanno (author)
Published by LAP Lambert Academic Publishing 2010-09-14 (2010)
ISBN 10: 3838394267 ISBN 13: 9783838394268
New paperback Quantity Available: > 20
Seller:
Blackwell's
(Oxford, OX, United Kingdom)
Rating
[?]

Book Description LAP Lambert Academic Publishing 2010-09-14, 2010. paperback. Condition: New. Seller Inventory # 9783838394268

More information about this seller | Contact this seller

Buy New
US$ 78.93
Convert currency

Add to Basket

Shipping: US$ 7.88
From United Kingdom to U.S.A.
Destination, rates & speeds

2.

Vella Bonanno, Patricia
ISBN 10: 3838394267 ISBN 13: 9783838394268
New Quantity Available: 1
Seller:
Rating
[?]

Book Description Condition: New. Publisher/Verlag: LAP Lambert Academic Publishing | A case study for Malta, prior to its becoming a Member State of the European Union | This case study originated from the need and willingness to implement managed change to the policy and practice for the introduction of new drugs into the national health service in Malta. A logic model was used to represent a descriptive evaluation(1999), to prioritise and document changes achieved from planned interventions and to present the final outcome evaluation(2003). This action research presents the subjective opinion of the author at that time. The methodology and findings can be generalised and applied. Hopefully those embarking on a challenge to bring about change in their organisation are encouraged to act. The study was finalised just before Malta's accession to the European Union (EU)(May 2004)and considered the possible impact of accession. With hindsight, the prediction that adoption of EU legislation would introduce a strong pharmaceutical framework which drives required changes and increases transparency in decision making proved to be correct. The issues with availability, affordability and equity of new drugs, which were a problem for Malta in 1999, remain, not only for Malta but also for other countries. | Format: Paperback | Language/Sprache: english | 352 pp. Seller Inventory # K9783838394268

More information about this seller | Contact this seller

Buy New
US$ 87.35
Convert currency

Add to Basket

Shipping: US$ 3.23
From Germany to U.S.A.
Destination, rates & speeds

3.

Patricia Vella Bonanno
Published by LAP Lambert Academic Publishing (2010)
ISBN 10: 3838394267 ISBN 13: 9783838394268
New Quantity Available: > 20
Print on Demand
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description LAP Lambert Academic Publishing, 2010. PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # LQ-9783838394268

More information about this seller | Contact this seller

Buy New
US$ 87.83
Convert currency

Add to Basket

Shipping: US$ 11.82
From United Kingdom to U.S.A.
Destination, rates & speeds

4.

Vella Bonanno, Patricia
Published by LAP Lambert Academic Publishing (2016)
ISBN 10: 3838394267 ISBN 13: 9783838394268
New Paperback Quantity Available: 1
Print on Demand
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)
Rating
[?]

Book Description LAP Lambert Academic Publishing, 2016. Paperback. Condition: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Seller Inventory # ria9783838394268_lsuk

More information about this seller | Contact this seller

Buy New
US$ 94.87
Convert currency

Add to Basket

Shipping: US$ 5.07
From United Kingdom to U.S.A.
Destination, rates & speeds

5.

Patricia Vella Bonanno
Published by LAP Lambert Academic Publishing (2010)
ISBN 10: 3838394267 ISBN 13: 9783838394268
New Quantity Available: > 20
Print on Demand
Seller:
Pbshop
(Wood Dale, IL, U.S.A.)
Rating
[?]

Book Description LAP Lambert Academic Publishing, 2010. PAP. Condition: New. New Book. Shipped from US within 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # IQ-9783838394268

More information about this seller | Contact this seller

Buy New
US$ 97.33
Convert currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, rates & speeds

6.

Patricia Vella Bonanno
Published by LAP Lambert Acad. Publ. Sep 2010 (2010)
ISBN 10: 3838394267 ISBN 13: 9783838394268
New Taschenbuch Quantity Available: 1
Seller:
Rheinberg-Buch
(Bergisch Gladbach, Germany)
Rating
[?]

Book Description LAP Lambert Acad. Publ. Sep 2010, 2010. Taschenbuch. Condition: Neu. Neuware - This case study originated from the need and willingness to implement managed change to the policy and practice for the introduction of new drugs into the national health service in Malta. A logic model was used to represent a descriptive evaluation(1999), to prioritise and document changes achieved from planned interventions and to present the final outcome evaluation(2003). This action research presents the subjective opinion of the author at that time. The methodology and findings can be generalised and applied. Hopefully those embarking on a challenge to bring about change in their organisation are encouraged to act. The study was finalised just before Malta's accession to the European Union (EU)(May 2004)and considered the possible impact of accession. With hindsight, the prediction that adoption of EU legislation would introduce a strong pharmaceutical framework which drives required changes and increases transparency in decision making proved to be correct. The issues with availability, affordability and equity of new drugs, which were a problem for Malta in 1999, remain, not only for Malta but also for other countries. 352 pp. Englisch. Seller Inventory # 9783838394268

More information about this seller | Contact this seller

Buy New
US$ 95.45
Convert currency

Add to Basket

Shipping: US$ 20.09
From Germany to U.S.A.
Destination, rates & speeds

7.

Patricia Vella Bonanno
Published by LAP Lambert Acad. Publ. Sep 2010 (2010)
ISBN 10: 3838394267 ISBN 13: 9783838394268
New Taschenbuch Quantity Available: 1
Seller:
BuchWeltWeit Inh. Ludwig Meier e.K.
(Bergisch Gladbach, Germany)
Rating
[?]

Book Description LAP Lambert Acad. Publ. Sep 2010, 2010. Taschenbuch. Condition: Neu. Neuware - This case study originated from the need and willingness to implement managed change to the policy and practice for the introduction of new drugs into the national health service in Malta. A logic model was used to represent a descriptive evaluation(1999), to prioritise and document changes achieved from planned interventions and to present the final outcome evaluation(2003). This action research presents the subjective opinion of the author at that time. The methodology and findings can be generalised and applied. Hopefully those embarking on a challenge to bring about change in their organisation are encouraged to act. The study was finalised just before Malta's accession to the European Union (EU)(May 2004)and considered the possible impact of accession. With hindsight, the prediction that adoption of EU legislation would introduce a strong pharmaceutical framework which drives required changes and increases transparency in decision making proved to be correct. The issues with availability, affordability and equity of new drugs, which were a problem for Malta in 1999, remain, not only for Malta but also for other countries. 352 pp. Englisch. Seller Inventory # 9783838394268

More information about this seller | Contact this seller

Buy New
US$ 95.45
Convert currency

Add to Basket

Shipping: US$ 20.09
From Germany to U.S.A.
Destination, rates & speeds

8.

Patricia Vella Bonanno
Published by LAP Lambert Acad. Publ. Sep 2010 (2010)
ISBN 10: 3838394267 ISBN 13: 9783838394268
New Taschenbuch Quantity Available: 1
Print on Demand
Seller:
AHA-BUCH GmbH
(Einbeck, Germany)
Rating
[?]

Book Description LAP Lambert Acad. Publ. Sep 2010, 2010. Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Neuware - This case study originated from the need and willingness to implement managed change to the policy and practice for the introduction of new drugs into the national health service in Malta. A logic model was used to represent a descriptive evaluation(1999), to prioritise and document changes achieved from planned interventions and to present the final outcome evaluation(2003). This action research presents the subjective opinion of the author at that time. The methodology and findings can be generalised and applied. Hopefully those embarking on a challenge to bring about change in their organisation are encouraged to act. The study was finalised just before Malta's accession to the European Union (EU)(May 2004)and considered the possible impact of accession. With hindsight, the prediction that adoption of EU legislation would introduce a strong pharmaceutical framework which drives required changes and increases transparency in decision making proved to be correct. The issues with availability, affordability and equity of new drugs, which were a problem for Malta in 1999, remain, not only for Malta but also for other countries. 352 pp. Englisch. Seller Inventory # 9783838394268

More information about this seller | Contact this seller

Buy New
US$ 95.45
Convert currency

Add to Basket

Shipping: US$ 34.61
From Germany to U.S.A.
Destination, rates & speeds

9.

Patricia Vella Bonanno
Published by LAP Lambert Academic Publishing, Germany (2010)
ISBN 10: 3838394267 ISBN 13: 9783838394268
New Paperback Quantity Available: 1
Seller:
The Book Depository EURO
(London, United Kingdom)
Rating
[?]

Book Description LAP Lambert Academic Publishing, Germany, 2010. Paperback. Condition: New. Language: English . Brand New Book. This case study originated from the need and willingness to implement managed change to the policy and practice for the introduction of new drugs into the national health service in Malta. A logic model was used to represent a descriptive evaluation(1999), to prioritise and document changes achieved from planned interventions and to present the final outcome evaluation(2003). This action research presents the subjective opinion of the author at that time. The methodology and findings can be generalised and applied. Hopefully those embarking on a challenge to bring about change in their organisation are encouraged to act. The study was finalised just before Malta s accession to the European Union (EU)(May 2004)and considered the possible impact of accession. With hindsight, the prediction that adoption of EU legislation would introduce a strong pharmaceutical framework which drives required changes and increases transparency in decision making proved to be correct. The issues with availability, affordability and equity of new drugs, which were a problem for Malta in 1999, remain, not only for Malta but also for other countries. Seller Inventory # KNV9783838394268

More information about this seller | Contact this seller

Buy New
US$ 143.18
Convert currency

Add to Basket

Shipping: US$ 3.94
From United Kingdom to U.S.A.
Destination, rates & speeds

10.

Patricia Vella Bonanno
Published by LAP Lambert Academic Publishing
ISBN 10: 3838394267 ISBN 13: 9783838394268
New Paperback Quantity Available: > 20
Seller:
BuySomeBooks
(Las Vegas, NV, U.S.A.)
Rating
[?]

Book Description LAP Lambert Academic Publishing. Paperback. Condition: New. 352 pages. Dimensions: 8.7in. x 5.9in. x 0.8in.This case study originated from the need and willingness to implement managed change to the policy and practice for the introduction of new drugs into the national health service in Malta. A logic model was used to represent a descriptive evaluation(1999), to prioritise and document changes achieved from planned interventions and to present the final outcome evaluation(2003). This action research presents the subjective opinion of the author at that time. The methodology and findings can be generalised and applied. Hopefully those embarking on a challenge to bring about change in their organisation are encouraged to act. The study was finalised just before Maltas accession to the European Union (EU)(May 2004)and considered the possible impact of accession. With hindsight, the prediction that adoption of EU legislation would introduce a strong pharmaceutical framework which drives required changes and increases transparency in decision making proved to be correct. The issues with availability, affordability and equity of new drugs, which were a problem for Malta in 1999, remain, not only for Malta but also for other countries. This item ships from multiple locations. Your book may arrive from Roseburg,OR, La Vergne,TN. Paperback. Seller Inventory # 9783838394268

More information about this seller | Contact this seller

Buy New
US$ 147.49
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds